BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34649440)

  • 1. Use of cellular exosomes as a new carrier in breast cancer gene therapy.
    Maleki N; Mirhakimi S; Babashah S; Sayadi A; Parnian G; Hadizadeh M
    Klin Onkol; 2021; 34(4):300-305. PubMed ID: 34649440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-cellular exosomes may have the role of a carrier in transferring molecules from the tumor micro-environment to the unaffected cells in breast cancer tumors.
    Khani SA; Kavousi M; Jamshidian F
    Klin Onkol; 2023; 37(6):462-466. PubMed ID: 38158235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
    Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
    Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
    Singh R; Pochampally R; Watabe K; Lu Z; Mo YY
    Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
    Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
    BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer.
    Donnarumma E; Fiore D; Nappa M; Roscigno G; Adamo A; Iaboni M; Russo V; Affinito A; Puoti I; Quintavalle C; Rienzo A; Piscuoglio S; Thomas R; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19592-19608. PubMed ID: 28121625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.
    Guo L; Zhu Y; Li L; Zhou S; Yin G; Yu G; Cui H
    Cancer Med; 2019 Sep; 8(12):5687-5701. PubMed ID: 31385464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
    Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
    J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
    Wang L; He M; Fu L; Jin Y
    Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells.
    Wei Y; Lai X; Yu S; Chen S; Ma Y; Zhang Y; Li H; Zhu X; Yao L; Zhang J
    Breast Cancer Res Treat; 2014 Sep; 147(2):423-31. PubMed ID: 25007959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating exosomal microRNAs as emerging non-invasive clinical biomarkers in heart failure: Mega bio-roles of a nano bio-particle.
    Zhou R; Wang L; Zhao G; Chen D; Song X; Momtazi-Borojeni AA; Yuan H
    IUBMB Life; 2020 Dec; 72(12):2546-2562. PubMed ID: 33053610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer.
    Xin Y; Wang X; Meng K; Ni C; Lv Z; Guan D
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31763681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
    Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
    Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
    Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer.
    Liu Q; Peng F; Chen J
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal miRNAs from highly metastatic cells can induce metastasis in non-metastatic cells.
    Kia V; Mortazavi Y; Paryan M; Biglari A; Mohammadi-Yeganeh S
    Life Sci; 2019 Mar; 220():162-168. PubMed ID: 30721706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.